CLINICAL_TRIALS
trial_result
· 2019-03-11
Clinical Trial Update: A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 Diabetes [Phase 1]
Summary
Phase 1 study evaluating insulin peglispro and glargine on fat metabolism in participants with Type 1 diabetes; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED | Results posted: 2019-03-11